Use of secondary preventive medications in patients with atherosclerotic disease in urban China: a cross-sectional study of 16, 860 patients.
BACKGROUND: Despite considerable improvements in the care of patients with cardiovascular disease in various populations over the last few decades, there are still limited data about long-term treatment patterns among patients with various atherosclerotic vascular conditions in China, especially the...
Main Authors: | Li, J, Chen, Y, Li, X, Armitage, J, Feng, F, Liu, J, Gao, Y, Zhang, H, Zhang, D, Hundei, W, Chen, Z, Chen, F, Hopewell, J, Valdes-Marquez, E, Landray, M, Jiang, L |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2012
|
Similar Items
-
Underuse of statins in patients with atherosclerotic ischemic stroke in China.
by: Li, X, et al.
Published: (2012) -
National survey of doctor-reported secondary preventive treatment for patients with acute coronary syndrome in China.
by: Li, J, et al.
Published: (2013) -
Effects of anacetrapib in patients with atherosclerotic vascular disease
by: Bowman, L, et al.
Published: (2017) -
[Current statin use for patients with atherosclerotic cardiovascular disease in 39 large Chinese hospitals].
by: Zhang, D, et al.
Published: (2011) -
Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease
by: Sammons, E, et al.
Published: (2021)